Publications in collaboration with researchers from Institute Paoli-Calmettes (1)

2024

  1. Atezolizumab Combined with Platinum and Maintenance Niraparib for Recurrent Ovarian Cancer with a Platinum-Free Interval >6 Months: ENGOT-OV41/GEICO 69-O/ANITA Phase III Trial

    Journal of Clinical Oncology, Vol. 42, Núm. 36, pp. 4294-4304